Center for Research on End-of-Life Care

You are here

Association between patient-provider communication and lung cancer stigma.

Association between patient-provider communication and lung cancer stigma.

Title
Publication TypeJournal Article
Year of Publication2016
AuthorsShen MJohnson, Hamann HA, Thomas AJ, Ostroff JS
JournalSupport Care Cancer
Volume24
Issue5
Pagination2093-9
Date Published2016 May
ISSN1433-7339
Abstract

PURPOSE: The majority (95 %) of lung cancer patients report stigma, with 48 % of lung cancer patients specifically reporting feeling stigmatized by their medical providers. Typically associated with the causal link to smoking and the historically poor prognosis, lung cancer stigma can be seen as a risk factor for poor psychosocial and medical outcomes in the context of lung cancer diagnosis and treatment. Thus, modifiable targets for lung cancer stigma-reducing interventions are needed. The present study sought to test the hypothesis that good patient-provider communication is associated with lower levels of lung cancer stigma.

METHODS: Lung cancer patients (n = 231) across varying stages of disease participated in a cross-sectional, multisite study designed to understand lung cancer stigma. Patients completed several survey measures, including demographic and clinical characteristics, a measure of patient-provider communication (Consumer Assessment of Healthcare Providers and Systems Program or CAHPS), and a measure of lung cancer stigma (Cataldo Lung Cancer Stigma Scale).

RESULTS: As hypothesized, results indicated that good patient-provider communication was associated with lower levels of lung cancer stigma (r = -0.18, p < 0.05). These results remained significant, even when controlling for relevant demographic and clinical characteristics (Stan. β = -0.15, p < 0.05).

CONCLUSIONS: Results indicate that good patient-provider communication is associated with lower levels of lung cancer stigma, suggesting that improving patient-provider communication may be a good intervention target for reducing lung cancer stigma.

DOI10.1007/s00520-015-3014-0
Alternate JournalSupport Care Cancer
PubMed ID26553030
PubMed Central IDPMC4805469
Grant List1R03CA154016 / CA / NCI NIH HHS / United States
KL2 TR000458 / TR / NCATS NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
R03 CA154016 / CA / NCI NIH HHS / United States
T32 CA009461 / CA / NCI NIH HHS / United States
T32-CA009461 / CA / NCI NIH HHS / United States
UL1 TR001105 / TR / NCATS NIH HHS / United States
UL1TR001105 / TR / NCATS NIH HHS / United States

Weill Cornell Medicine Center for Research on End-of-Life Care 525 E 68th St, Box 39,
1414 Baker Pavilion
New York, NY 10065 Phone: (212) 746-4409